JAGUAR HEALTH INC stock forecast: up to 17.33 USD JAGX stock price prognosis


Forecast for Fri 17 Nov 2023 price 42.15

JAGUAR HEALTH INC stock price forecast for further price development up to 3057.92% (time horizon: 1 day) and price target of 17.33 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) JAGUAR HEALTH INC share price prediction for 2023-11-17 with daily closed price projections

Key Facts

Symbol JAGX 

ISIN US47010C4096 

CUSIP 47010C409

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (-0.30)

News <--> Close correlation for next day influence (-0.09)

Finance numbers

Revenue 9,757,000.0

Earnings per share -0.54

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

Napo formed Jaguar to develop and commercialize animal health products. A significant proportion of patients undergoing cancer therapy experience diarrhea. NIAID is part of the National Institutes of Health. In these people, rapid loss of body fluids leads to dehydration and shock. Without treatment, death can occur within hours. Ten members of the Jaguar and Napo team have been together for more than 15 years. Top line results for the study are expected to be available in the second half of 2021. At that point in time, enrollment in the study exceeded 85%. Through Napo, we hold an extensive global patent portfolio. Key members of this team successfully developed Mytesi. Napo is receiving preclinical services from the NIAID to support lechlemer development. Crofelemer was well tolerated at all doses. The infection is often mild or without symptoms, but can sometimes be severe. We are investigating lechlemer for the indication of cholera/general watery diarrhea. Diarrhea predominant irritable bowel syndrome. Crofelemer represents a new tool in gastrointestinal disease management. The FDA may request additional information rather than accept an NDA for filing. We do not believe that our non-prescription products fit within this framework either. On November 6, 2018, the Defendants moved to dismiss the second amended complaint. 8203;Corporate InformationWe were incorporated in the State of Delaware on June 6, 2013. We plan to rely on certain of these issued patents as protection for Canalevia. Similar changes in laws or regulations can occur in other countries. The reason for the volatility in our stock is not well understood and may continue. This is often referred to as a "short squeeze."

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 29.53/100
    • Good financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.

Bollinger Bollinger Bands for JAGUAR HEALTH INC can provide the information where the market is moving based on price information.

JAGUAR HEALTH INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns JAGUAR HEALTH INC.

On-Balance Volume information for JAGUAR HEALTH INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for JAGUAR HEALTH INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for JAGUAR HEALTH INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for JAGUAR HEALTH INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for JAGUAR HEALTH INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for JAGUAR HEALTH INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for JAGUAR HEALTH INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-10-13 17.33 2023-09-23 08:03
2023-09-29 5.69 2023-09-23 08:03
2023-09-25 1.28 2023-09-23 08:03
2023-09-26 2.32 2023-09-23 08:03
2023-10-20 22.54 2023-09-23 08:03
2023-10-04 9.30 2023-09-23 08:03
2023-10-05 10.45 2023-09-23 08:03
2023-10-11 15.07 2023-09-23 08:03
2023-09-27 3.30 2023-09-23 08:03
2023-09-28 4.43 2023-09-23 08:03
2023-10-02 6.88 2023-09-23 08:03
2023-10-03 8.11 2023-09-23 08:03
2023-11-10 37.67 2023-09-23 08:03
2023-11-08 35.80 2023-09-23 08:03
2023-10-06 11.54 2023-09-23 08:03
2023-11-02 31.90 2023-09-23 08:03
2023-10-16 18.40 2023-09-23 08:03
2023-10-18 20.43 2023-09-23 08:03
2023-10-09 12.77 2023-09-23 08:03
2023-10-10 13.97 2023-09-23 08:03
2023-10-27 27.84 2023-09-23 08:03
2023-10-23 23.60 2023-09-23 08:03
2023-10-24 24.67 2023-09-23 08:03
2023-10-17 19.42 2023-09-23 08:03
2023-11-03 32.89 2023-09-23 08:03
2023-10-12 16.21 2023-09-23 08:03
2023-10-19 21.49 2023-09-23 08:03
2023-11-09 36.74 2023-09-23 08:03
2023-10-25 25.72 2023-09-23 08:03
2023-10-26 26.78 2023-09-23 08:03
2023-11-06 33.87 2023-09-23 08:03
2023-11-07 34.84 2023-09-23 08:03
2023-10-30 28.88 2023-09-23 08:03
2023-10-31 29.89 2023-09-23 08:03
2023-11-01 30.89 2023-09-23 08:03
2023-11-16 41.27 2023-09-23 08:03
2023-11-15 40.38 2023-09-23 08:03
2023-11-13 38.59 2023-09-23 08:03
2023-11-14 39.49 2023-09-23 08:03
2023-11-17 42.15 2023-09-23 08:03

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.